LITERATURE DETAILS |
MAPPING DATA |
EXPERIMENTAL DATA |
MAPS RELATION DATA |
DOWNLOAD PDF
Change literature
Experimental data:
Add injection data
* First time you log in, please close the new tab and click on again.
Click on individual boxes to expand/collapse data
| MIMCT2002_42 | |
Injection data |
| Injections Citation |
Five animals reveived varying WGA-HRP injections in the visual areas of one hemisphere. The largest injection site (Fig. 5A) included most of area 17 dorso-ventrally, most of area 18 and the posterior part of area 19. |
| Injections RefText |
415 |
| Injections RefFigures |
5 |
| Injections Hemisphere |
|
| Injection Volume |
0.5 ul |
| Injections Concentration |
30% HRP and 10%WGA-HRP |
| Injections Laminae |
|
| Edit injection data |
|
Site of injection |
| Acronym Name |
Acronym Full Name |
Brain Sites Type Name |
| 17 |
primary visual cortex |
Area_Ctx_3D |
Edit site of injection | | |
|
Injection outcomes |
Add labeling outcome
|
Injection method |
Add injection method
| Tracers Name |
Reference Text |
Reference Figures |
Bilateral Use |
Injection Method |
Survival Time |
Section Thickness |
Number Of Sections |
| WGA-HRP |
127 |
5A |
N |
pressure |
3 days |
75um |
|
Edit injection method |
| | | | | | |
|
|
| MIMCT2002_43 | |
Injection data |
| Injections Citation |
Five animals reveived varying WGA-HRP injections in the visual areas of one hemisphere. The largest injection site (Fig. 5A) included most of area 17 dorso-ventrally, most of area 18 and the posterior part of area 19. |
| Injections RefText |
415 |
| Injections RefFigures |
5 |
| Injections Hemisphere |
|
| Injection Volume |
0.5 ul |
| Injections Concentration |
30% HRP and 10%WGA-HRP |
| Injections Laminae |
|
| Edit injection data |
|
Site of injection |
| Acronym Name |
Acronym Full Name |
Brain Sites Type Name |
| 18 |
second visual cortical area |
Area_Ctx_3D |
Edit site of injection | | |
|
Injection outcomes |
Add labeling outcome
|
Injection method |
Add injection method
| Tracers Name |
Reference Text |
Reference Figures |
Bilateral Use |
Injection Method |
Survival Time |
Section Thickness |
Number Of Sections |
| WGA-HRP |
127 |
5A |
N |
pressure |
3 days |
75um |
|
Edit injection method |
| | | | | | |
|
|
| MIMCT2002_44 | |
Injection data |
| Injections Citation |
Five animals reveived varying WGA-HRP injections in the visual areas of one hemisphere. The largest injection site (Fig. 5A) included most of area 17 dorso-ventrally, most of area 18 and the posterior part of area 19. |
| Injections RefText |
415 |
| Injections RefFigures |
5 |
| Injections Hemisphere |
|
| Injection Volume |
0.5 ul |
| Injections Concentration |
30% HRP and 10%WGA-HRP |
| Injections Laminae |
|
| Edit injection data |
|
Site of injection |
| Acronym Name |
Acronym Full Name |
Brain Sites Type Name |
| 19 |
third visual cortical area |
Area_Ctx_3D |
Edit site of injection | | |
|
Injection outcomes |
Add labeling outcome
|
Injection method |
Add injection method
| Tracers Name |
Reference Text |
Reference Figures |
Bilateral Use |
Injection Method |
Survival Time |
Section Thickness |
Number Of Sections |
| WGA-HRP |
127 |
5A |
N |
pressure |
3 days |
75um |
|
Edit injection method |
| | | | | | |
|
|
| MIMCT2002_45 | |
Injection data |
| Injections Citation |
The injection sites of the BDA or fluorescent beads series were widely distributed over the lateral and suprasylvian gyri, and tipically involved parts of area 17, the whole of areas 18, 19 and 21, and beyond. |
| Injections RefText |
416 |
| Injections RefFigures |
5 |
| Injections Hemisphere |
|
| Injection Volume |
? |
| Injections Concentration |
5% |
| Injections Laminae |
|
| Edit injection data |
|
Site of injection |
| Acronym Name |
Acronym Full Name |
Brain Sites Type Name |
| 17 |
primary visual cortex |
Area_Ctx_3D |
Edit site of injection | | |
|
Injection outcomes |
Add labeling outcome
|
Injection method |
Add injection method
| Tracers Name |
Reference Text |
Reference Figures |
Bilateral Use |
Injection Method |
Survival Time |
Section Thickness |
Number Of Sections |
| BDA |
127 |
5 |
N |
Hamilton Syringe |
2 weeks |
50 um |
|
Edit injection method |
| | | | | | |
|
|
| MIMCT2002_46 | |
Injection data |
| Injections Citation |
The injection sites of the BDA or fluorescent beads series were widely distributed over the lateral and suprasylvian gyri, and tipically involved parts of area 17, the whole of areas 18, 19 and 21, and beyond. |
| Injections RefText |
416 |
| Injections RefFigures |
5 |
| Injections Hemisphere |
|
| Injection Volume |
? |
| Injections Concentration |
5% |
| Injections Laminae |
|
| Edit injection data |
|
Site of injection |
| Acronym Name |
Acronym Full Name |
Brain Sites Type Name |
| 18 |
second visual cortical area |
Area_Ctx_3D |
Edit site of injection | | |
|
Injection outcomes |
Add labeling outcome
|
Injection method |
Add injection method
| Tracers Name |
Reference Text |
Reference Figures |
Bilateral Use |
Injection Method |
Survival Time |
Section Thickness |
Number Of Sections |
| BDA |
127 |
5 |
N |
Hamilton Syringe |
2 weeks |
50 um |
|
Edit injection method |
| | | | | | |
|
|
| MIMCT2002_47 | |
Injection data |
| Injections Citation |
The injection sites of the BDA or fluorescent beads series were widely distributed over the lateral and suprasylvian gyri, and tipically involved parts of area 17, the whole of areas 18, 19 and 21, and beyond. |
| Injections RefText |
416 |
| Injections RefFigures |
5 |
| Injections Hemisphere |
|
| Injection Volume |
? |
| Injections Concentration |
5% |
| Injections Laminae |
|
| Edit injection data |
|
Site of injection |
| Acronym Name |
Acronym Full Name |
Brain Sites Type Name |
| 19 |
third visual cortical area |
Area_Ctx_3D |
Edit site of injection | | |
|
Injection outcomes |
Add labeling outcome
|
Injection method |
Add injection method
| Tracers Name |
Reference Text |
Reference Figures |
Bilateral Use |
Injection Method |
Survival Time |
Section Thickness |
Number Of Sections |
| BDA |
127 |
5 |
N |
Hamilton Syringe |
2 weeks |
50 um |
|
Edit injection method |
| | | | | | |
|
|
| MIMCT2002_48 | |
Injection data |
| Injections Citation |
The injection sites of the BDA or fluorescent beads series were widely distributed over the lateral and suprasylvian gyri, and tipically involved parts of area 17, the whole of areas 18, 19 and 21, and beyond. |
| Injections RefText |
416 |
| Injections RefFigures |
5 |
| Injections Hemisphere |
|
| Injection Volume |
? |
| Injections Concentration |
5% |
| Injections Laminae |
|
| Edit injection data |
|
Site of injection |
| Acronym Name |
Acronym Full Name |
Brain Sites Type Name |
| 21 |
fourth visual cortical area |
Area_Ctx_3D |
Edit site of injection | | |
|
Injection outcomes |
Add labeling outcome
|
Injection method |
Add injection method
| Tracers Name |
Reference Text |
Reference Figures |
Bilateral Use |
Injection Method |
Survival Time |
Section Thickness |
Number Of Sections |
| WGA-HRP |
127 |
5A |
N |
pressure |
3 days |
75um |
|
Edit injection method |
| | | | | | |
|
|
Quit zoom
| MIMCT2002_42 | |
Injection data |
| Injections Citation |
Five animals reveived varying WGA-HRP injections in the visual areas of one hemisphere. The largest injection site (Fig. 5A) included most of area 17 dorso-ventrally, most of area 18 and the posterior part of area 19. |
| Injections RefText |
415 |
| Injections RefFigures |
5 |
| Injections Hemisphere |
|
| Injection Volume |
0.5 ul |
| Injections Concentration |
30% HRP and 10%WGA-HRP |
| Injections Laminae |
|
| Edit injection data |
|
Site of injection |
| Acronym Name |
Acronym Full Name |
Brain Sites Type Name |
| 17 |
primary visual cortex |
Area_Ctx_3D |
Edit site of injection | | |
|
Injection outcomes |
Add labeling outcome
|
Injection method |
Add injection method
| Tracers Name |
Reference Text |
Reference Figures |
Bilateral Use |
Injection Method |
Survival Time |
Section Thickness |
Number Of Sections |
| WGA-HRP |
127 |
5A |
N |
pressure |
3 days |
75um |
|
Edit injection method |
| | | | | | |
|
|
| MIMCT2002_43 | |
Injection data |
| Injections Citation |
Five animals reveived varying WGA-HRP injections in the visual areas of one hemisphere. The largest injection site (Fig. 5A) included most of area 17 dorso-ventrally, most of area 18 and the posterior part of area 19. |
| Injections RefText |
415 |
| Injections RefFigures |
5 |
| Injections Hemisphere |
|
| Injection Volume |
0.5 ul |
| Injections Concentration |
30% HRP and 10%WGA-HRP |
| Injections Laminae |
|
| Edit injection data |
|
Site of injection |
| Acronym Name |
Acronym Full Name |
Brain Sites Type Name |
| 18 |
second visual cortical area |
Area_Ctx_3D |
Edit site of injection | | |
|
Injection outcomes |
Add labeling outcome
|
Injection method |
Add injection method
| Tracers Name |
Reference Text |
Reference Figures |
Bilateral Use |
Injection Method |
Survival Time |
Section Thickness |
Number Of Sections |
| WGA-HRP |
127 |
5A |
N |
pressure |
3 days |
75um |
|
Edit injection method |
| | | | | | |
|
|
| MIMCT2002_44 | |
Injection data |
| Injections Citation |
Five animals reveived varying WGA-HRP injections in the visual areas of one hemisphere. The largest injection site (Fig. 5A) included most of area 17 dorso-ventrally, most of area 18 and the posterior part of area 19. |
| Injections RefText |
415 |
| Injections RefFigures |
5 |
| Injections Hemisphere |
|
| Injection Volume |
0.5 ul |
| Injections Concentration |
30% HRP and 10%WGA-HRP |
| Injections Laminae |
|
| Edit injection data |
|
Site of injection |
| Acronym Name |
Acronym Full Name |
Brain Sites Type Name |
| 19 |
third visual cortical area |
Area_Ctx_3D |
Edit site of injection | | |
|
Injection outcomes |
Add labeling outcome
|
Injection method |
Add injection method
| Tracers Name |
Reference Text |
Reference Figures |
Bilateral Use |
Injection Method |
Survival Time |
Section Thickness |
Number Of Sections |
| WGA-HRP |
127 |
5A |
N |
pressure |
3 days |
75um |
|
Edit injection method |
| | | | | | |
|
|
| MIMCT2002_45 | |
Injection data |
| Injections Citation |
The injection sites of the BDA or fluorescent beads series were widely distributed over the lateral and suprasylvian gyri, and tipically involved parts of area 17, the whole of areas 18, 19 and 21, and beyond. |
| Injections RefText |
416 |
| Injections RefFigures |
5 |
| Injections Hemisphere |
|
| Injection Volume |
? |
| Injections Concentration |
5% |
| Injections Laminae |
|
| Edit injection data |
|
Site of injection |
| Acronym Name |
Acronym Full Name |
Brain Sites Type Name |
| 17 |
primary visual cortex |
Area_Ctx_3D |
Edit site of injection | | |
|
Injection outcomes |
Add labeling outcome
|
Injection method |
Add injection method
| Tracers Name |
Reference Text |
Reference Figures |
Bilateral Use |
Injection Method |
Survival Time |
Section Thickness |
Number Of Sections |
| BDA |
127 |
5 |
N |
Hamilton Syringe |
2 weeks |
50 um |
|
Edit injection method |
| | | | | | |
|
|
| MIMCT2002_46 | |
Injection data |
| Injections Citation |
The injection sites of the BDA or fluorescent beads series were widely distributed over the lateral and suprasylvian gyri, and tipically involved parts of area 17, the whole of areas 18, 19 and 21, and beyond. |
| Injections RefText |
416 |
| Injections RefFigures |
5 |
| Injections Hemisphere |
|
| Injection Volume |
? |
| Injections Concentration |
5% |
| Injections Laminae |
|
| Edit injection data |
|
Site of injection |
| Acronym Name |
Acronym Full Name |
Brain Sites Type Name |
| 18 |
second visual cortical area |
Area_Ctx_3D |
Edit site of injection | | |
|
Injection outcomes |
Add labeling outcome
|
Injection method |
Add injection method
| Tracers Name |
Reference Text |
Reference Figures |
Bilateral Use |
Injection Method |
Survival Time |
Section Thickness |
Number Of Sections |
| BDA |
127 |
5 |
N |
Hamilton Syringe |
2 weeks |
50 um |
|
Edit injection method |
| | | | | | |
|
|
| MIMCT2002_47 | |
Injection data |
| Injections Citation |
The injection sites of the BDA or fluorescent beads series were widely distributed over the lateral and suprasylvian gyri, and tipically involved parts of area 17, the whole of areas 18, 19 and 21, and beyond. |
| Injections RefText |
416 |
| Injections RefFigures |
5 |
| Injections Hemisphere |
|
| Injection Volume |
? |
| Injections Concentration |
5% |
| Injections Laminae |
|
| Edit injection data |
|
Site of injection |
| Acronym Name |
Acronym Full Name |
Brain Sites Type Name |
| 19 |
third visual cortical area |
Area_Ctx_3D |
Edit site of injection | | |
|
Injection outcomes |
Add labeling outcome
|
Injection method |
Add injection method
| Tracers Name |
Reference Text |
Reference Figures |
Bilateral Use |
Injection Method |
Survival Time |
Section Thickness |
Number Of Sections |
| BDA |
127 |
5 |
N |
Hamilton Syringe |
2 weeks |
50 um |
|
Edit injection method |
| | | | | | |
|
|
| MIMCT2002_48 | |
Injection data |
| Injections Citation |
The injection sites of the BDA or fluorescent beads series were widely distributed over the lateral and suprasylvian gyri, and tipically involved parts of area 17, the whole of areas 18, 19 and 21, and beyond. |
| Injections RefText |
416 |
| Injections RefFigures |
5 |
| Injections Hemisphere |
|
| Injection Volume |
? |
| Injections Concentration |
5% |
| Injections Laminae |
|
| Edit injection data |
|
Site of injection |
| Acronym Name |
Acronym Full Name |
Brain Sites Type Name |
| 21 |
fourth visual cortical area |
Area_Ctx_3D |
Edit site of injection | | |
|
Injection outcomes |
Add labeling outcome
|
Injection method |
Add injection method
| Tracers Name |
Reference Text |
Reference Figures |
Bilateral Use |
Injection Method |
Survival Time |
Section Thickness |
Number Of Sections |
| WGA-HRP |
127 |
5A |
N |
pressure |
3 days |
75um |
|
Edit injection method |
| | | | | | |
|
|
